Facebook
Twitter
LinkedIn
ForwardAUA/Saudi Urological Association: Best of AUA2017 Annual Meeting (2017)
Based on the expertise of course directors and AUA faculty incorporating adult learning principles for the delivery of evidence-based education, this live activity was designed utilizing a combination of instructional modalities including, didactic lectures, case study discussions, small group interactions, and question/answer sessions. This combination of instructional methods provides the knowledge and competence training and testing that facilitates the learners having achieved the course objectives upon completion of the course.
Target Audience
- APN/PA
- Nurse
- Resident
- Urologist
Learning Objectives
After attending this activity, participants will be able to:
- Describe recent developments in the medical and surgical management of urology patients
- Identify new technologies for the treatment of urologic problems
- Analyze the potential challenges to urologic practice and specify possible solutions
- Integrate the latest guidelines on the management of urological diseases into their practice
AUA/Saudi Urological Association: Best of AUA 2017 Annual Meeting
26-28 October 2017
Riyadh, The Kingdom of Saudi Arabia
King Faisal Specialist Hospital and Research Center (KFSHRC)
Course Directors and Local Organizing Committee: Raed A. Azhar, MD, MSc, FRCSC, FACS, Mohammed Alotaibi MD, MBA, FRCSC, Ashraf Abusamra MD, FRCSC, FSUO, and Waleed Altaweel, MD, FRCSC
PROGRAM AGENDA (updated 9/14/17)
Thursday, 26 October 2017
07:30 – 08:30 | Registration | |
08:30 – 08:35 | SUA Welcome Remarks - Raed A. Azhar, M.D. AUA Welcome Remarks – Inderbir S. Gill, M.D.
| |
08:35 – 12:00 | Live Surgery: Oncology 1 case by Dr. Inderbir Gill and 1 case Dr. Seth Lerner King Salman Auditorium To be confirmed: Dr. Gill: robotic radical cystectomy + intra-corporeal neobladder
Dr. Lerner suggestions: Cystectomy with local faculty performing the diversion
11:00 – 11:15 Morning Break
| Pediatric Urology – Craig Peters, MD PGC Auditorium
09:15 – 09:35 Prenatal Hydronephrosis: Current Approaches and Practical Guidelines
09:35 – 09:55 VUR and UTI in Children – What do the Guidelines Tell Us?
09:55 – 10:15 Cryptorchidism and the new AUA Guidelines – Current Practice
10:15 – 11:00 Case Discussions (SUA faculty to present/AUA faculty as panelist)
11:00 – 11:15 Morning Break
11:15 – 11:45 AUA Highlights lecture
|
12:00 – 14:00 | Afternoon Break
| |
14:00 – 17:00 | Live Surgery: 1 Pediatric Urology Robotic Surgery – Dr. Craig Peters PGC Auditorium
To be confirmed: pyeloplasty, ureteral reimplantation, or hypospadias | Oncology (Kidney Cancer) – Dr. Inderbir Gill
2:00 – 2:15 Highlights of AUA lecture - Dr. Gill
2:15 – 2:45 Robotic Urologic Oncologic Surgery: State-of-the-Art - Dr. Gill
2:45 – 3:10 Robotic Inferior Vena Cava Thrombectomy Surgery: The Next Frontier- Dr. Gill
3:10 – 3:30 Coffee Break
3:30 – 4:00 Indications for renal preservation in management of Upper tract urothelial cancer – Dr. Seth Lerner
4:00 – 5:00 Case Discussions (SUA faculty to present/AUA faculty as panelist) Drs. Gill and Lerner
|
Friday, 27 October 2017 07:30 – 09:00 Resident Breakfast with the Experts – Pediatric Urology
Craig Peters, MD
PGC Auditorium
08:30 –11:00 Bladder Cancer – Seth Lerner, MD
King Salman Auditorium + PGC Auditorium
08:30 – 09:00 Highlights of AUA lecture
09:00 – 09:20 Risk stratified approach to treatment of NMIBC
09:20 – 09:40 What to do when patients recur after BCG?
09:40 – 10:20 Case Discussions (SUA faculty to present/AUA faculty as panelist)
10:20 – 11:00 Bladder Cancer Tumor Board
(SUA faculty to present/AUA faculty as panelist)
11:00 – 11:15 Morning Break
11:15 – 15:30 Prostate Cancer – Drs. Inderbir Gill and Seth LernerKing Salman Auditorium + PGC Auditorium
11:15 – 11:25 Highlights of AUA lecture
Inderbir Gill, MD
11:25 – 11:45 Prostate Cancer: Targeted Biopsies & Focal Therapy Inderbir Gill, MD
11:45 – 12:00 Role of surgery in locally advanced oligo-metastatic disease Seth Lerner, MD
12:00 – 14:00 Afternoon Break
14:00 – 14:30 Case Discussions (SUA faculty to present/AUA faculty as panelist) – Drs. Gill & Lerner
14:30 – 15:10 Prostate Cancer Tumor Board
(SUA faculty to present/AUA faculty as panelist) – Drs. Gill & Lerner
15:10 – 15:30 Coffee Break
15:30 – 17:30 Urolithiasis and Endourology – Dean Assimos, MD
King Salman Auditorium + PGC Auditorium
15:30 – 15:50 Highlights of AUA lecture
15:50 – 16:10 State-of-the-Art: Surgical Treatment of Urolithiasis
16:10 – 16:30 Endourology complications how to avoid them and how to manage
16:30 – 16:50 Stone prevention: Where we are now and where we need to go?
16:50 – 17:30 Case Discussions (SUA faculty to present/AUA faculty as panelist)
Saturday, 28 October 2017
07:30 – 08:30 Resident Breakfast with the Expert – BPH and Voiding Dysfunction
Claus Roehrborn, MD
PGC Auditorium
08:30 –11:00 BPH and Voiding Dysfunction - Claus Roehrborn, MD
King Salman Auditorium + PGC Auditorium
08:30 – 09:00 Highlights of AUA lecture: Male voiding dysfunction and BPH: Update form the AUA 2017
09:00 – 09:35 Minimally invasive surgical treatments for LUTS/BPH: have they finally come off age?
09:35 – 10:00 Unresolved issues in the assessment and management of MLUTS/BPH
10:00 – 10:30 Case Discussions (SUA faculty to present/AUA faculty as panelist)
10:30 – 11:00 Update on medical therapy for MLUTS / BPH
11:00 – 11:15 Morning Break
11:15 – 15:00 Andrology and Sexual Dysfunction – Ajay Nehra, MD
King Salman Auditorium + PGC Auditorium
11:15 – 11:30 Highlights of AUA Lecture
11:30 – 11:50 Erectile dysfunction: medical and surgical management
11:50 – 12:10 Erectile dysfunction: A marker of Cardiovascular disease
12:10 – 14:00 Afternoon Break
14:00 – 14:20 Peyronie's disease medical and surgical management
14:20 – 15:00 Case Discussions (SUA faculty to present/AUA faculty as panelist)
15:00 Adjournment
| nderbir S. Gill, MD, MCh | Speaker | Nothing to Disclose | |||
| Dean G. Assimos, MD | Speaker | Nothing to Disclose | |||
| Seth P. Lerner, MD, FACS | Speaker | Nothing to Disclose | |||
| Craig A. Peters, MD, FAAP, FACS | Speaker | Nothing to Disclose |
| Inderbir S. Gill, MD, MCh | Speaker | Nothing to Disclose | |||
| Seth P. Lerner, MD, FACS | Speaker | Nothing to Disclose | |||
| Craig A. Peters, MD, FAAP, FACS | Speaker | Nothing to Disclose | |||
| Waleed Mohammad Altaweel | Speaker | Nothing to Disclose |
| Ajay Nehra, MD | Speaker | Nothing to Disclose | |||
| Claus G. Roehrborn, MD | Speaker | Astellas nymox | Scientific Study or Trial Consultant or Advisor | Yes Yes | 04/03/2017 11/21/2017 |
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity for a maximum of 18.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Available Credit
- 18.00 AMA PRA Category 1 Credit™
- 18.00 Non-Physician Participation